Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 64

Sort by

Sort Order Select

Journal Articles

Combating “Referral Madness Syndrome”in Classical Hematology

Charles Greenberg, Kimberley Youkhana, Benjamin Djulbegovic

Blood (2024) 144 (Supplement 1): 3643.

https://doi.org/10.1182/blood-2024-212250

Published: 2024

Journal Articles

Management and Treatment of Bleeding and Thrombotic Complications of Congenital Afibrinogenemia during Chemotherapy and Bone Marrow Transplant for B-ALL

Kimberley Youkhana, Alexander Coltoff, Tharakeswari Selvakumar, Benjamin Djulbegovic, Charles Greenberg, Shayla Bergmann

Blood (2024) 144 (Supplement 1): 5507.

https://doi.org/10.1182/blood-2024-208793

Published: 2024

Journal Articles

Optimal Duration of Anticoagulation for Unprovoked Venous Thromboembolism: A Threshold Decision Analysis Model

Kimberley Youkhana, Charles Greenberg, Benjamin Djulbegovic

Blood (2024) 144 (Supplement 1): 2264.

https://doi.org/10.1182/blood-2024-208900

Published: 2024

Journal Articles

Sinusoidal Obstruction Syndrome (SOS) Biomarkers-Derived Predictive Model to Individualize SOS Preemption in Patients Undergoing Allogeneic Stem Cell Transplant

Sophie Paczesny, Iztok Hozo, Benjamin Djulbegovic

Blood (2023) 142 (Supplement 1): 4895.

https://doi.org/10.1182/blood-2023-172813

Published: 2023

Journal Articles

Comparison of Khorana Vs. Onkotev Predictive Score to Individualize Anticoagulant Prophylaxis in Ambulatory Patients with Cancer

Chiara Alessandra Cella, Nicola Fazio, Florian Lordick, Vincenzo Bagnardi, Samuele Frassoni, Lorenzo Gervaso, Carmine Valenza, Iztok Hozo, Benjamin Djulbegovic

Blood (2023) 142 (Supplement 1): 661.

https://doi.org/10.1182/blood-2023-172815

Published: 2023

Journal Articles

Diagnostic Predictive Model for Diagnosis of Heart Failure after Hematopoietic Cell Transplantation (HCT): Comparison of Traditional Statistical with Machine Learning Modeling

Benjamin Djulbegovic, MD, Jennifer Berano Teh, Lennie Wong, PhD, Iztok Hozo, PhD, Saro H. Armenian, DO, MPH

Blood (2019) 134 (Supplement_1): 5799.

https://doi.org/10.1182/blood-2019-130764

Published: 2019

Journal Articles

Amino Bisphosphonates Are Associated with Decreased Mortality Compared to Non-Amino Bisphosphonates in the Treatment of Multiple Myeloma

Marianne Razavi, PhD, Rahul Mhaskar, MPH, Benjamin Djulbegovic, MD

Blood (2018) 132 (Supplement 1): 5638.

https://doi.org/10.1182/blood-2018-99-116976

Published: 2018

Journal Articles

How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations

Benjamin Djulbegovic, MD, Tea Reljic, MPH, Shira Elqayam, PhD, Adam Cuker, MD MS, Iztok Hozo, PhD, Qi Zhou, PhD, Shelly-Anne Li, PhDc), Paul Alexander, PhD, Nieuwlaat Robby, PhD, Wojtek Wiercioch, MD, Holger Schünemann, MD, Gordon Guyatt, MD

Blood (2018) 132 (Supplement 1): 4707.

https://doi.org/10.1182/blood-2018-99-110132

Published: 2018

Journal Articles

The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines

Shelly-Anne Li, PhD, Paul Alexander, PhD, Tea Reljic, MPH, Adam Cuker, MD MS, Nieuwlaat Robby, PhD, Wojtek Wiercioch, MD, Gordon Guyatt, MD, Holger Schünemann, MD, Benjamin Djulbegovic, MD

Blood (2018) 132 (Supplement 1): 2237.

https://doi.org/10.1182/blood-2018-99-111367

Published: 2018

Journal Articles

Hypomethylating Agents Versus Intensive Chemotherapy in Elderly Patients (Age ≥ 70) with Acute Myeloid Leukemia with High White Blood Cell Count

Chetasi Talati, MD, Andrew Kuykendall, MD, Najla Al Ali, M.Sc, Jongphil Kim, Marina Sehovic, Kenneth S. Zuckerman, MD, David A Sallman, MD, Eric Padron, MD, Alan F. List, MD, Rami S. Komrokji, MD, Benjamin Djulbegovic, MD, Martine Extermann, MD, Kendra L. Sweet, MD, Jeffrey E. Lancet, MD

Blood (2017) 130 (Supplement 1): 3911.

https://doi.org/10.1182/blood.V130.Suppl_1.3911.3911

Published: 2017

Journal Articles

Comparison of Survival Outcomes in Elderly Acute Myeloid Leukemia Patients (Age ≥ 70) When Treated with Azacitidine or Decitabine As an Initial Treatment Modality

Chetasi Talati, MD, Andrew Kuykendall, MD, Najla Al Ali, M.Sc, Jongphil Kim, Marina Sehovic, Kenneth S. Zuckerman, MD, David A Sallman, MD, Alan F List, MD, Eric Padron, MD, Rami S. Komrokji, MD, Benjamin Djulbegovic, MD, Martine Extermann, MD, Kendra Sweet, MD, Jeffrey E. Lancet, MD

Blood (2017) 130 (Supplement 1): 3912.

https://doi.org/10.1182/blood.V130.Suppl_1.3912.3912

Published: 2017

Journal Articles

Predictive Tool to Support Decision-Making about Management of Conflicts of Interest for Guideline Development: Derivation and Validation

Mak Djulbegovic, Stephanie Jaffe, Tea Reljic, Jason Beckstead, Adam Cuker, MD MS, Rob Kunkle, Benjamin Djulbegovic, MD

Blood (2017) 130 (Supplement 1): 4661.

https://doi.org/10.1182/blood.V130.Suppl_1.4661.4661

Published: 2017

Journal Articles

Effect of NPM1 Mutation on Prognosis and Therapeutic Efficacy in Patients Aged ≥70 Years with Acute Myeloid Leukemia

Chetasi Talati, MD, Andrew Kuykendall, MD, Najla Al Ali, M.Sc, Jongphil Kim, Marina Sehovic, Kenneth S. Zuckerman, MD, David A Sallman, MD, Alan F. List, MD, Eric Padron, MD, Rami S. Komrokji, MD, Benjamin Djulbegovic, MD, Martine Extermann, MD, Kendra Sweet, MD, Jeffrey E. Lancet, MD

Blood (2017) 130 (Supplement 1): 2676.

https://doi.org/10.1182/blood.V130.Suppl_1.2676.2676

Published: 2017

Journal Articles

Outcomes in Older Adults (age ≥ 70) with Acute Myeloid Leukemia Based on Choice of Frontline Treatment for Proliferative or Non-Proliferative Phenotype

Blood (2017) 130 (Supplement 1): 1412.

https://doi.org/10.1182/blood.V130.Suppl_1.1412.1412

Published: 2017

Journal Articles

Negative Impact of FLT3-ITD Mutation in Elderly Acute Myeloid Leukemia Patients (Age ≥70) Is Karyotype Dependent

Blood (2017) 130 (Supplement 1): 1413.

https://doi.org/10.1182/blood.V130.Suppl_1.1413.1413

Published: 2017

Journal Articles

Type of Therapy May Influence Outcomes in Patients over Age 70 with Acute Myeloid Leukemia: A Systematic Review of More Than 11,000 Patients

Martine Extermann, MD PhD, Marina Sehovic, MD MPH, Tea Reljic, MPH, Jongphil Kim, PhD, Jeffrey E. Lancet, MD, Benjamin Djulbegovic, MD PhD

Blood (2016) 128 (22): 3998.

https://doi.org/10.1182/blood.V128.22.3998.3998

Published: 2016

Journal Articles

When Should Patients Older Than 70 with Acute Myeloid Leukemia be Treated?

Jongphil Kim, Martine Extermann, MD PhD, Jeffrey E. Lancet, MD, Najla H Al Ali, Tea Reljic, MPH, Marina Sehovic, MD MPH, Varun C Dhulipala, MD, Benjamin Djulbegovic, MD PhD

Blood (2016) 128 (22): 4007.

https://doi.org/10.1182/blood.V128.22.4007.4007

Published: 2016

Journal Articles

Improving Hospice Referral: Application of Regret-Based Decision Modeling at End-of-Life Care

Benjamin Djulbegovic, MD PhD, Athanasios Tsalatsanis, PhD, Rahul Mhaskar, MPH, PhD, Iztok Hozo, PhD, Branko Miladinovic, PhD, Howard Tuch, MD PhD

Blood (2016) 128 (22): 535.

https://doi.org/10.1182/blood.V128.22.535.535

Published: 2016

Journal Articles

Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of over 600 Patients

Varun C Dhulipala, MD, Martine Extermann, MD PhD, Najla Al Ali, Jongphil Kim, Marina Sehovic, MD MPH, Tea Reljic, Benjamin Djulbegovic, MD PhD, Jeffrey E Lancet, MD

Blood (2015) 126 (23): 2505.

https://doi.org/10.1182/blood.V126.23.2505.2505

Published: 2015

Journal Articles

Meta-Analysis Evaluating Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation As Front-Line Consolidation in Chronic Lymphocytic Leukemia: Results Do Not Justify This Treatment Approach

Tea Reljic, M.S., Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD, Mohamed A Kharfan-Dabaja, MD

Blood (2014) 124 (21): 1306.

https://doi.org/10.1182/blood.V124.21.1306.1306

Published: 2014

NARROW

Combating “Referral Madness Syndrome”in Classical Hematology

Management and Treatment of Bleeding and Thrombotic Complications of Congenital Afibrinogenemia during Chemotherapy and Bone Marrow Transplant for B-ALL

Optimal Duration of Anticoagulation for Unprovoked Venous Thromboembolism: A Threshold Decision Analysis Model

Sinusoidal Obstruction Syndrome (SOS) Biomarkers-Derived Predictive Model to Individualize SOS Preemption in Patients Undergoing Allogeneic Stem Cell Transplant

Comparison of Khorana Vs. Onkotev Predictive Score to Individualize Anticoagulant Prophylaxis in Ambulatory Patients with Cancer

Diagnostic Predictive Model for Diagnosis of Heart Failure after Hematopoietic Cell Transplantation (HCT): Comparison of Traditional Statistical with Machine Learning Modeling

Amino Bisphosphonates Are Associated with Decreased Mortality Compared to Non-Amino Bisphosphonates in the Treatment of Multiple Myeloma

How Do ASH Guidelines Panels Make Decisions? Association between Decision Making Factors and the Strength of Recommendations

The Influence of Activity Roles and Use of a Structured Framework on Developing Hematology Clinical Practice Guidelines

Hypomethylating Agents Versus Intensive Chemotherapy in Elderly Patients (Age ≥ 70) with Acute Myeloid Leukemia with High White Blood Cell Count

Comparison of Survival Outcomes in Elderly Acute Myeloid Leukemia Patients (Age ≥ 70) When Treated with Azacitidine or Decitabine As an Initial Treatment Modality

Predictive Tool to Support Decision-Making about Management of Conflicts of Interest for Guideline Development: Derivation and Validation

Effect of NPM1 Mutation on Prognosis and Therapeutic Efficacy in Patients Aged ≥70 Years with Acute Myeloid Leukemia

Outcomes in Older Adults (age ≥ 70) with Acute Myeloid Leukemia Based on Choice of Frontline Treatment for Proliferative or Non-Proliferative Phenotype

Negative Impact of FLT3-ITD Mutation in Elderly Acute Myeloid Leukemia Patients (Age ≥70) Is Karyotype Dependent

Type of Therapy May Influence Outcomes in Patients over Age 70 with Acute Myeloid Leukemia: A Systematic Review of More Than 11,000 Patients

When Should Patients Older Than 70 with Acute Myeloid Leukemia be Treated?

Improving Hospice Referral: Application of Regret-Based Decision Modeling at End-of-Life Care

Survival Comparison Amongst Commonly Used Frontline Regimens in Patients Age 70 Years and Older with Acute Myeloid Leukemia (AML): A Single-Institution Study of over 600 Patients

Meta-Analysis Evaluating Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation As Front-Line Consolidation in Chronic Lymphocytic Leukemia: Results Do Not Justify This Treatment Approach

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only